LIFE TECHNOLOGIES INC
SC 13D/A, EX-99, 2000-09-15
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: LIFE TECHNOLOGIES INC, SC 13D/A, 2000-09-15
Next: INTEGRATED RESOURCES HIGH EQUITY PARTNERS SERIES 85, 10-K/A, 2000-09-15




                                                                       EXHIBIT 1

                  THIS GROUP AGREEMENT, dated as of September 14, 2000, is among
International Specialty Products Inc. ("ISP") and the other parties signatory
hereto (collectively with ISP, the "Investors").

                  WHEREAS, the Agreement and Plan of Merger between Invitrogen
Corporation ("Invitrogen") and Life Technologies, Inc. ("LT"), dated as of July
7, 2000 (the "Merger Agreement") is scheduled to be voted on by the LT
stockholders on September 14, 2000; and

                  WHEREAS, ISP has been considering the exercise of dissenters'
rights with respect to the 3,506,270 shares of common stock of LT (the "ISP LT
Shares") held of record by ISP and its subsidiaries (for the purposes of this
Group Agreement, ISP and such subsidiaries are referred to collectively as
"ISP");

                  NOW, THEREFORE, each of the Investors agrees to the following:

                  1.       If, within 120 days after the effective date of the
                           Merger, ISP settles its dissenter's right of
                           appraisal and receives a per share consideration in
                           excess of $60 per ISP LT Share, each Investor who has
                           received Investor Excess Cash (as defined in
                           paragraph 2) shall be entitled to share on a pro rata
                           basis (as described in paragraph 2) the total
                           consideration received by ISP to the extent, and only
                           to the extent, that the per share consideration
                           received by ISP is in excess of $60. The
                           consideration ISP receives in settlement of its
                           dissenter's right of appraisal shall be valued as a
                           sum of (i) any cash received, plus (ii) with respect
                           to any securities received and still held by ISP at 4
                           P.M. EST on the third business day after such
                           receipt, the reported closing price of such
                           securities on such third business day, plus (iii)
                           with respect to any securities received and then sold
                           by ISP prior to 4 P.M. EST on the third business day
                           after such receipt, the total proceeds received from
                           such sales.

                                       1
<PAGE>

                  2.       If, within 120 days after the effective date of the
                           merger of LT with and into Invitrogen Corporation
                           (the "Merger"), either (i) ISP has not settled its
                           dissenters' rights claims or (ii) ISP has effectively
                           withdrawn its dissenters' rights claims and receives
                           the Standard Election Consideration (as defined in
                           the Merger Agreement), then if and to the extent that
                           an Investor other than ISP receives cash in excess of
                           what it would have received had ISP not exercised its
                           dissenters' rights and instead made a cash election
                           (in the aggregate, the "Investor Excess Cash"), ISP,
                           at its option, shall transfer to each such Investor a
                           number of shares of Invitrogen stock and shall
                           receive from each such Investor an amount of cash in
                           exchange therefor such that after giving effect to
                           such transfers each of such Investors shall have
                           shared on a pro rata basis with ISP (i.e., based on
                           the total number of shares owned by such Investor
                           with respect to which it makes an all-cash election
                           as compared to the total number of shares making an
                           all-cash election owned by all such Investors plus
                           the shares owned by ISP) the total cash consideration
                           received by all the Investors, including ISP,
                           pursuant to the Merger Agreement. If any such
                           transfer occurs it shall occur within three business
                           days following the receipt by ISP of the Standard
                           Election Consideration. For the purpose of
                           determining the number of shares to be transferred in
                           exchange for the cash the shares of Invitrogen shall
                           be valued at $60 per share.

                  3.       If ISP determines not to exercise its dissenters'
                           rights with respect to the ISP LT Shares, the
                           agreements contained in paragraphs 1 and 2 of this
                           Group Agreement shall be null and void. If any
                           Investor determines not to make an all-cash election
                           pursuant to the Merger Agreement with respect to any
                           of the LT Shares held by it (the "No Cash Election

                                       2
<PAGE>

                           Shares"), such Investor shall not be bound by
                           paragraph 2, and shall not have any right to enforce
                           any benefit contained in paragraph 1 or 4, of this
                           Group Agreement with respect to such No Cash Election
                           Shares.

                  4.       All legal fees and expenses incurred by the Investors
                           incident to realizing that to which Investors are
                           entitled upon consummation of the Invitrogen merger
                           shall be borne by the Investors pro rata (without
                           regard to the $5,000 limit set forth in the previous
                           Group Agreements dated November 25, 1998, December 1,
                           1998 and July 18, 2000) to the extent such total fees
                           are less than or equal to $15,000, except that legal
                           fees and expenses incurred by ISP in connection with
                           the perfection of ISP's appraisal rights underss. 262
                           of the Delaware General Corporation Law and ISP's
                           participation in any adjudication, arbitration or
                           other discussion of valuation thereunder shall be
                           borne by ISP.

                  5.       Any and all disputes arising under or relating to the
                           performance or breach of this letter agreement shall
                           be resolved in accordance with the Commercial
                           Arbitration Rules of the American Arbitration
                           Association ("AAA") by a single arbitrator selected
                           from the Complex Litigation panel of the AAA. The
                           hearings shall be held in New York City and judgment
                           on the arbitrator's award may be entered in the state
                           or federal courts sitting in the City of New York.

                  Kindly confirm your acceptance of the above by signing below.
This letter agreement shall be valid if executed in counterparts which all
together shall constitute the same instrument and shall not be effective until a
signed counterpart from each Investor is received by ISP.


                                       3
<PAGE>

                  IN WITNESS WHEREOF, the undersigned have duly executed this
Agreement as of the date written above.

                              INTERNATIONAL SPECIALTY
                              PRODUCTS INC.


                              By  /s/  Susan B. Yoss
                                 -------------------------------------------
                                 Name:  Susan B. Yoss
                                 Title:  Senior Vice President and Treasurer


                              Shares Beneficially Owned:  3,506,270





                                       4
<PAGE>

                  IN WITNESS WHEREOF, the undersigned have duly executed this
Agreement as of the date written above.


                              THE COHEN REVOCABLE TRUST


                              By /s/ S. Cohen
                                 -------------------------------------------
                                 Name:  S. Cohen
                                 Title:   Trustee

                              Shares Beneficially Owned:  397,100





                                       5
<PAGE>



                  IN WITNESS WHEREOF, the undersigned have duly executed this
Agreement as of the date written above.


                              BEAR, STEARNS & CO. INC.



                              By /s/ Barry Cohen
                                 -------------------------------------------
                                 Name:  Barry Cohen
                                 Title:  Senior Managing Director

                                 Shares Beneficially Owned:  300,000




                                       6
<PAGE>



                  IN WITNESS WHEREOF, the undersigned have duly executed this
Agreement as of the date written above.


                                 /s/ Frederick R. Adler
                                 -------------------------------------------
                                 Frederick Adler

                                 Shares Beneficially Owned:  714,895








                                       7
<PAGE>


                  IN WITNESS WHEREOF, the undersigned have duly executed this
Agreement as of the date written above.

                                 /s/ Annie Chang
                                 -------------------------------------------
                                 Annie Chang

                                 Shares Beneficially Owned:  135,500








                                       8
<PAGE>



                  IN WITNESS WHEREOF, the undersigned have duly executed this
Agreement as of the date written above.

                                 BEAR, STEARNS & CO. INC.



                                 By /s/ Barry Cohen
                                    --------------------------------------
                                    Name:  Barry Cohen
                                    Title:  Senior Managing Director

                                    Shares Beneficially Owned:  47,651
                                    (shares held in market-making account)





                                       9


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission